±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 2007  |  »Ø¸´: 36
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

snakebaby88

¾èÖú¹ó±ö (³õÈëÎÄ̳)


[½»Á÷] ÕÐÆ¸in vivo pharmacology director - Diabetes

¾ßÌ幤×÷µØµã:
Shanghai
н½ð:
Äêн80ÍòÒÔÉÏ
ѧÀúºÍÑо¿·½Ïò:
²©Ê¿¼°²©Ê¿ÒÔÉÏ
ÕÐÆ¸¸Úλ:
Ò©Àí¸ºÔðÈË
¹«Ë¾Ãû³Æ:
A Leading Global CRO, full range service of pre-clinical service
ÁªÏµ·½Ê½:
iris-hu@weelite.cn or haj616@vip.sina.com

Duties and Responsibilities
•        Working with IVP and local site leadership to develop site IVP service strategy and execute the plan.
•        Accountable for development and growth of the site IVP services.
•        Engage with new and existing clients in collaboration with account executives to develop solutions to client study needs
•        Train technical staff in the conduct of in vivo models and methods
•        Develop study protocols and ensure that the protocol, including any changes, is approved and complies with appropriate SOPs, GRP/GLPs, and regulatory agency guidelines
•        Develop study protocols aligned with IACUC requirements to support internal and external projects.
•        Coordinate efforts of study teams in the execution of client studies
•        Monitor progress and status of studies.  Ensure that all experimental data and relevant events, including unanticipated findings, errors and deviations, are accurately recorded and are reconstructable
•        Preparation of study reports, including incorporation and review of contributor reports, for review and submission to clients
•        Participate in or hosts client visits
•        Support internal and/or client QA audits
Education/Qualifications
•        PhD in Pharmacology or relevant and equivalent degree.  
Experience
•        5-8or more years of relevant drug discovery experience in a pharmaceutical or biotechnology company setting
•        In vivo model expertise and experience required
•        Experience in Diabetes and Metabolic Disease research and models preferred
•        Experience in leading and coordinating study conduct in a matrixed resource environment preferred

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

iswalle

½ð³æ (ÕýʽдÊÖ)


¡ï
snakebaby88(½ð±Ò+1): лл²ÎÓë
O(¡É_¡É)O

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
7Â¥2013-08-08 14:36:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 37 ¸ö»Ø´ð

wswsjz

ľ³æ (Ö°Òµ×÷¼Ò)


¡ï
snakebaby88(½ð±Ò+1): лл²ÎÓë
Wish all the best wishes for you
4Â¥2013-08-08 14:28:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
shanlingbnu10Â¥
2013-08-08 15:06   »Ø¸´  
¼Ù´ó¿Õ12Â¥
2013-08-08 15:15   »Ø¸´  
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 274Çóµ÷¼Á +4 xiao°®Í¬Ñ§ 2026-03-30 4/200 2026-03-31 00:04 by jp9609
[¿¼ÑÐ] ºÏ·ÊÇøÓòÐÔÖØµãÒ»±¾ÕÐÊÕµ÷¼Á +4 6266jl 2026-03-30 4/200 2026-03-30 21:48 by zhuangyan123
[¿¼ÑÐ] 22408 359·Öµ÷¼Á +4 Qshers 2026-03-27 7/350 2026-03-30 21:30 by Qshers
[¿¼ÑÐ] »·¾³¹¤³Ì 085701£¬267Çóµ÷¼Á +7 minht 2026-03-29 7/350 2026-03-30 20:46 by dophin1985
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +8 hyl3153942 2026-03-29 8/400 2026-03-30 20:45 by dophin1985
[¿¼ÑÐ] ¸÷λÀÏʦºÃ£¬ÎÒµÄһ־ԸΪ±±¾©¿Æ¼¼´óѧ085601²ÄÁÏר˶ +10 Koxui 2026-03-28 10/500 2026-03-30 19:33 by Ô´_2020
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸9£¬³õÊԳɼ¨£º338£¬ËÄÁù¼¶Òѹý£¬ÓпÆÑо­Àú£¬Çóµ÷¼Á£¡ +7 Zuhui0306 2026-03-25 7/350 2026-03-30 19:01 by Ô´_2020
[¿¼ÑÐ] 296Çóµ÷¼Á +10 ±Ë°¶t 2026-03-29 10/500 2026-03-30 10:50 by ̽123
[¿¼ÑÐ] 311Çóµ÷¼Á +6 ¶¬Ê®Èý 2026-03-24 6/300 2026-03-29 20:45 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 349Çóµ÷¼Á +6 Àîľ×Ó°¡¹þ¹þ 2026-03-25 6/300 2026-03-29 12:47 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 298Çóµ÷¼Á +3 ÖÖÊ¥´Í 2026-03-29 3/150 2026-03-29 12:06 by longlotian
[¿¼ÑÐ] µ÷¼Á¿¼ÑÐ +3 Íõ½ÜÒ» 2026-03-29 3/150 2026-03-29 08:09 by fmesaito
[¿¼ÑÐ] 081200-314 +3 LILIQQ 2026-03-27 4/200 2026-03-28 09:41 by ±£»¤µØÇòÄãÎÒ×öÆ
[¿¼ÑÐ] Ò»Ö¾Ô¸ Î÷±±´óѧ ×Ü·Ö282 Ó¢ÓïÒ»62 Çóµ÷¼Á +7 18419759900 2026-03-25 8/400 2026-03-27 16:38 by 18419759900
[¿¼ÑÐ] 0703»¯Ñ§338Çóµ÷¼Á£¡ +6 Zuhui0306 2026-03-26 7/350 2026-03-27 10:35 by shangxh
[˶²©¼ÒÔ°] ±±¾©ÁÖÒµ´óѧ˶µ¼ÕÐÉú¹ã¸æ +6 kongweilin 2026-03-26 8/400 2026-03-27 10:18 by FF_16
[¿¼ÑÐ] Çóµ÷¼Á +6 ÁÖ֮Ϧ 2026-03-24 6/300 2026-03-27 08:38 by hypershenger
[¿¼ÑÐ] ×Ü·Ö322ÇóÉúÎïѧ/Éú»¯Óë·Ö×Ó/ÉúÎïÐÅϢѧÏà¹Øµ÷¼Á +5 ÐdzÁuu 2026-03-26 6/300 2026-03-26 19:02 by macy2011
[¿¼ÑÐ] 085602 289·ÖÇóµ÷¼Á +8 WWWÎ÷Î÷¸¥Ë¹ 2026-03-24 8/400 2026-03-26 16:33 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 302Çóµ÷¼Á +4 ½õÒÂÎÀÌÙ½· 2026-03-25 4/200 2026-03-25 16:29 by ¹¦·ò·è¿ñ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û